Showing results (201-210 of 541) with videos related to
Sort By:
Pageof 55
Antimicrobial Agents and Chemotherapy|May 23, 2003
Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection modelBéatrice Seignères, Perrine Martin, Bettina Werle, et al.Journal of Hepatology|June 8, 2013
Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapyFabien Lavocat, Paul Dény, Christian Pichoud, et al.Antiviral Research|June 6, 2007
Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivityCatalin Lazar, David Durantel, Alina Macovei, et al.Molecular Therapy. Methods & Clinical Development|December 17, 2025
HBVZ10, an AAV8 vector-based new HBV therapy candidate for cccDNA eliminationBai-Hua Zhang, Yuanping Zhou, Stephen Horrigan, et al.The Lancet. Gastroenterology & Hepatology|April 15, 2019
A global scientific strategy to cure hepatitis BPeter A Revill, Francis V Chisari, Joan M Block, et al.Frontiers in Immunology|February 22, 2021
Nucleic Acid-Induced Signaling in Chronic Viral Liver DiseaseArmando Andres Roca Suarez, Barbara Testoni, Thomas F Baumert, et al.Frontiers in Cellular and Infection Microbiology|September 20, 2023
Interspecies comparison of the early transcriptomic changes associated with hepatitis B virus exposure in human and macaque immune cell populationsArmando Andres Roca Suarez, Séverine Planel, Xavier Grand, et al.Journal of Medical Virology|June 29, 2004
Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assaysDamien Jeantet, Isabelle Chemin, Bernard Mandrand, et al.Antiviral Research|November 25, 2017
Low incidence of precore W28* mutant variants in treated hepatitis B virus and human immunodeficiency virus co-infected patientsAnders Boyd, Karine Lacombe, Fabien Lavocat, et al.Oncogene|May 29, 2003
HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53Andreas Klein, Eva Guhl, Yin-Jeh Tzeng, et al.Pageof 55